Early adaptation and acquired resistance to CDK4/6 inhibition in estrogen receptor-positive breast cancer.
Times cited: 42
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.
Science Translational Medicine.
Times cited: 91